Established in February 2019 the BeNeLux & France (BNLF) Local Chapter is an offspring of the Controlled Release Society (CRS) Inc., 1978 USA, a worldwide association and home for experts dedicated to the delivery of activities, including delivery scientists, engineers, clinicians, and technical professionals.
The BNLF Local Chapter aims to bring together scientists in the fields of drug delivery and nanomedicine located in Belgium, the Netherlands, Luxembourg and France. We stimulate scientific knowledge exchange and collaborations between industrial and academic experts, provide networks and represent at a local level the Controlled Release Society (CRS).
Supported by the CRS, we contribute to local meetings and conferences, keep our members up to date with the news in the field and provide a platform to share job opportunities and scientific content.
Our Chapter has two main objectives:
1. bring together local drug delivery and nanomedicine experts from industry and academia by providing them with a networking platform, stimulating scientific knowledge exchange and collaborations;
2. support early career scientists by boosting their network and professional
development, sharing career opportunities, creating mentorship and exchange
programs.
Being our member, you will be able to keep up with the latest news in the drug
delivery/nanomedicine fields and expand your local network in academic and
industrial sectors. Our Chapter consists of more than 150 top researchers in the field including professors, assistant and associate professors, early career scientists and industrial representatives from four European countries.
Read more about us on the CRS website and do not hesitate to contact us by email, LinkedIn and Twitter if you have any question or need more information about the Chapter.
-
Branche
-
Geneesmiddelenproductie
-
Bedrijfsgrootte
-
1 medewerker
-
Hoofdkantoor
-
Groningen, Netherlands
-
Type
-
Non-profit
-
Opgericht
-
2018
-
Specialismen
-
drugdelivery, drugrelease, drugdevelopment, biomedicine, biotechnology, controlledrelease, nanomedicine en drugformulation